Published in J Gerontol A Biol Sci Med Sci on July 01, 1995
Studying the interaction of alpha-gal carbohydrate antigen and proteins by quartz-crystal microbalance. J Am Chem Soc (2003) 0.93
Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing. J Immunol (2011) 0.91
α-Gal Nanoparticles in Wound and Burn Healing Acceleration. Adv Wound Care (New Rochelle) (2017) 0.75
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. J Exp Med (1985) 2.37
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proc Natl Acad Sci U S A (1987) 2.27
The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J Immunol (1974) 2.19
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev (2001) 1.78
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med (1987) 1.38
Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol (1979) 1.24
Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest (1992) 1.22
Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest (2000) 1.20
Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry (1990) 1.19
Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation (1998) 1.18
Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest (1986) 1.15
Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol (1989) 1.13
Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity. J Immunol (1975) 1.11
The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer (1976) 1.09
Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation (2000) 1.09
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Cancer Res (1982) 1.08
One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood (1993) 1.06
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res (1999) 1.04
Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem (1987) 1.02
Lectin-induced apoptosis of tumour cells. Glycobiology (1993) 1.02
Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection. Cancer Res (1995) 1.01
Age-associated changes in subpopulations of human lymphocytes. Clin Immunol Immunopathol (1977) 1.01
Natural species-restricted attachment of human and murine T lymphocytes to various cells. Proc Natl Acad Sci U S A (1978) 1.00
Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage. Transplantation (1998) 0.99
Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features. J Exp Med (1980) 0.99
Activated T cells in the synovial fluid of arthritic patients. II. In vitro activation of the autologous blood lymphocytes. J Immunol (1981) 0.98
The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. J Biol Chem (2000) 0.96
Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme. Glycobiology (1994) 0.95
Human T lymphocyte receptors for sheep red blood cells and specific antigens: are they identical sites on the cell membrane? J Immunol (1977) 0.92
Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol (1995) 0.91
Separation and characteristics of tumor-infiltrating lymphocytes in man. Contemp Top Immunobiol (1980) 0.91
Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin Diagn Lab Immunol (1995) 0.91
Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes. Clin Immunol Immunopathol (1975) 0.91
A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology (1996) 0.90
Be13, a human T-leukemia cell line highly sensitive to dexamethasone-induced cytolysis. Cancer Res (1984) 0.90
The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions. J Immunol (1976) 0.89
EA rosette formation: a simple means to increase sensitivity of the antiglobulin test in patients with anti red cell antibodies. Br J Haematol (1981) 0.87
Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody. Vaccine (1996) 0.86
Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells. Blood (1991) 0.86
Lymphocytes of Hodgkin's biopsies exhibit: stable E-rosette formation, natural attachment and glucocorticoid sensitivity, similar to immunoactivated T cells. Clin Immunol Immunopathol (1980) 0.85
Interaction between anti-Gal and human tumor cells: a natural defense mechanism? J Natl Cancer Inst (1989) 0.85
Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. J Gen Virol (1994) 0.85
Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation (1997) 0.85
Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection. Cancer Res (1997) 0.84
The alpha-galactosyl epitope on human normal and autoimmune thyroid cells. Autoimmunity (1991) 0.84
Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose. Cancer Res (1996) 0.84
Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma. Int J Cancer (1980) 0.83
Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice. Mol Immunol (2000) 0.83
Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms. Clin Exp Metastasis (1993) 0.83
Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris. Glycobiology (2001) 0.83
Studies on the formation of E-rosettes by human T lymphocytes and thymus cells. Effects of temperature, metabolic inhibitors and anti-T sera. Isr J Med Sci (1975) 0.82
Analysis of the peanut agglutinin-binding site as a differentiation marker of normal and malignant human lymphoid cells. Clin Exp Immunol (1981) 0.82
Analysis of the basis for persistence of herpes simplex virus type 1 in undifferentiated U937 cells. Viral Immunol (1992) 0.82
A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells. Prog Clin Biol Res (1985) 0.81
Effects of dexamethasone on proliferation of autologous fibroblasts and on the immune profile in women undergoing pelvic surgery for infertility. Fertil Steril (1983) 0.81
Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection. Transplantation (1997) 0.81
Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. J Immunol (1994) 0.81
Use of the enzyme-linked immunoadsorbent assay to monitor the purification of glycosphingolipid antigens by high-performance liquid chromatography. Anal Biochem (1987) 0.81
alpha-galactosyl epitopes on glycoproteins of porcine renal extracellular matrix. Kidney Int (2000) 0.80
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation (1998) 0.80
Differential expression of alpha-Gal epitopes on pig and mouse organs. Transplant Proc (2000) 0.80
The alpha-galactosyl epitope on mammalian thyroid cells. Acta Endocrinol (Copenh) (1991) 0.80
The in vitro sensitivity of leukemic and normal leukocytes to hydrocortisone induced cytolysis. Blood (1980) 0.80
Loss of net negative surface charge during MLC stimulation of human T lymphocytes: correlation to "stable" E-rosette formation and natural attachment to normal and malignant target cells. Cell Immunol (1979) 0.80
alpha-Gal epitopes on viral glycoproteins. Subcell Biochem (1999) 0.79
Molecular localization of abortive infection of resident peritoneal macrophages by herpes simplex virus type 1. J Virol (1989) 0.79
Erythrocyte membrane alterations in beta-thalassaemia. Clin Haematol (1985) 0.79
Association between HLA determinants and complement receptors on human lymphocytes. Tissue Antigens (1977) 0.79
The rosetting antiglobulin test as a means of determining the D zygosity of human red cells. Vox Sang (1984) 0.79
Human T lymphocytes become glucocorticoid-sensitive upon immune activation. Cell Immunol (1980) 0.79
Preventing anti-Gal response in xenograft recipients by an alpha-Gal toxin. Transplant Proc (2001) 0.78
Transient expression of virus-specific promoters in murine resident peritoneal macrophages. J Leukoc Biol (1990) 0.78
Specific attachment of T-lymphocytes from cancer patients to tumor cells. Cancer Lett (1977) 0.78
Glucocorticoid induced cytolysis of human normal and malignant lymphocytes. J Steroid Biochem (1983) 0.77
Structure function studies of a New World monkey alpha 1,3galactosyltransferase. Analysis of alternative splicing and expression in baculovirus system. Subcell Biochem (1999) 0.77
Interaction of baboon anti-alpha-galactosyl antibody with pig tissues. Am J Pathol (1999) 0.77
Antigenic differences between T and B lymphocytes in man. Isr J Med Sci (1974) 0.77
T cells interacting with the alpha-Gal epitope: studies in alpha1, 3Galactosyltransferase knock-out mice. Transplant Proc (2000) 0.77
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. Transplantation (1998) 0.77
Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation. Transplant Proc (2000) 0.76
Excessive binding of the natural anti-alpha-galactosyl IgG to sickle red cells: enhancement of red cell destruction by a physiological process. Trans Assoc Am Physicians (1985) 0.76
alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli. Glycobiology (1995) 0.76
Identification of B cells with receptors for alpha-Gal epitopes (Galalpha 1-3Galbeta1-4GlcNac-R) in xenograft recipients. Transplant Proc (2000) 0.76
A simple in vitro site directed mutagenesis of concatamerized cDNA by inverse polymerase chain reaction. Nucleic Acids Res (1992) 0.75
Enhancement of autologous tumor vaccine immunogenicity by anti-Gal. Subcell Biochem (1999) 0.75